Safety And Efficacy Study Of The Combination Of CpG 7909 And Herceptin In Patients With Metastatic Breast Cancer
Summary
The registered summary isn't in our current data snapshot. Read it on the ClinicalTrials.gov record ↗. Why? →
Investigators
The overall officials registered on this study. Names that resolve to a findmyKOL profile link to it; the rest are shown as registered.
- Harold Burstein, M.D., Ph.D.
Dana-Farber Cancer Institute
Principal Investigator
A profile link is shown only when the registered name resolves to a person record with a confident, namesake-checked match; ambiguous names stay unlinked.
Sites
8 registered facilities, with the per-site recruitment status where the registry publishes one. ClinicalTrials.gov does not publish per-site enrollment counts.
- Univ. of Connecticut Health Center
Farmington, Connecticut, United States
- Cancer Research Network, Inc.
Plantation, Florida, United States
- Greenebaum Cancer Center at Univ. of Maryland
Baltimore, Maryland, United States
- Dana-Farber Cancer Institute
Boston, Massachusetts, United States
- Comprehensive Cancer Center, University of Michigan
Ann Arbor, Michigan, United States
- Cancer Center at Saint Barnabas Medical Center
Livingston, New Jersey, United States
- Univ. of Pittsburgh Cancer Institute, Magee Women'S Hosp.
Pittsburgh, Pennsylvania, United States
- Fletcher Allen Health Care
Burlington, Vermont, United States
Site investigator names are published by ClinicalTrials.gov only while a study recruits, so completed studies list sites without them.
Drugs studied
No drug or biological interventions are in our data for this study — it may test a procedure, device or behavioral intervention, or the intervention list isn't in our current snapshot. See the registry record ↗. Why? →
Registration & key dates
Registry attributes as recorded on the ClinicalTrials.gov study record.
- Start
- 31 Oct 2001
- Primary completion
- 30 Jun 2003
- Completion
- 30 Jun 2003
- Last update posted
- 30 May 2011
- Registered enrollment
- 12
- Registry id
- NCT00031278
Source: ClinicalTrials.gov, via the CTTI AACT database, data as of 12 Jul 2026. Registry facts are shown as registered by the study sponsor; findmyKOL does not interpret them.